Abstract
The gut microbiome has been increasingly recognized as a key player in the development and progression of colon cancer. Alterations in the gut microbiota, known as dysbiosis, can lead to a variety of medical issues. Microbial adaptation through signals and small molecules can enhance pathogen colonization and modulate host immunity, significantly impacting disease progression. Quorum sensing peptides and molecules have been linked to the progression of colon cancer. Various interventions, such as fecal microbiota transplantation, probiotics, prebiotics, synbiotics, and antibiotics, have been used to reverse dysbiosis with mixed results and potential side effects. Thus, a personalized approach to treatment selection based on patient characteristics, such as individual gut microbiota manipulation, is necessary to prevent and treat diseases like colon cancer. With advances in metagenomic sequencing and other omics technologies, there has been a growing interest in developing precision medicine strategies for microbial imbalance-induced colon cancer. This review serves as a comprehensive synthesis of current knowledge on the gut microbiome involvement in colon cancer. By exploring the potential of utilizing the gut microbiome as a target for precision medicine, this review underscores the exciting opportunities that lie ahead. Although challenges exist, the integration of microbiome data into precision medicine approaches has the potential to revolutionize the management of colon cancer, providing patients with more personalized and effective treatment options.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Change history
21 September 2023
A Correction to this paper has been published: https://doi.org/10.1007/s12223-023-01094-4
References
Abed J, Emgård JEM, Zamir G et al (2016) Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20:215–225. https://doi.org/10.1016/j.chom.2016.07.006
Ahmad R, Kumar B, Chen Z et al (2017) Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Oncogene 36:6592–6604. https://doi.org/10.1038/onc.2017.259
Ambalam P, Raman M, Purama RK, Doble M (2016) Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol 30:119–131. https://doi.org/10.1016/j.bpg.2016.02.009
Amedei A, Boem F (2018) I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine. Int J Mol Sci 19:E3756. https://doi.org/10.3390/ijms19123756
Bahmani S, Azarpira N, Moazamian E (2019) Anti-colon cancer activity of Bifidobacterium metabolites on colon cancer cell line SW742. Turk J Gastroenterol 30:835–842. https://doi.org/10.5152/tjg.2019.18451
Bajire SK, Jain S, Johnson RP, Shastry RP (2021) 6-Methylcoumarin attenuates quorum sensing and biofilm formation in Pseudomonas aeruginosa PAO1 and its applications on solid surface coatings with polyurethane. Appl Microbiol Biotechnol 105:8647–8661. https://doi.org/10.1007/s00253-021-11637-9
Behrouzi A, Nafari AH, Siadat SD (2019) The significance of microbiome in personalized medicine. Clin Transl Med 8:16. https://doi.org/10.1186/s40169-019-0232-y
Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C et al (2013) Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS One 8:e59370. https://doi.org/10.1371/journal.pone.0059370
Bernstein H, Bernstein C, Payne CM et al (2005) Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589:47–65. https://doi.org/10.1016/j.mrrev.2004.08.001
Booth LA, Gilmore IT, Bilton RF (1997) Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res 26:135–144. https://doi.org/10.3109/10715769709097792
Borges-Canha M, Portela-Cidade JP, Dinis-Ribeiro M et al (2015) Role of colonic microbiota in colorectal carcinogenesis: a systematic review. Rev Esp Enferm Dig 107:659–671. https://doi.org/10.17235/reed.2015.3830/2015
Brody H (2020) The gut microbiome. Nature 577:S5. https://doi.org/10.1038/d41586-020-00194-2
Buc E, Dubois D, Sauvanet P et al (2013) High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 8:e56964. https://doi.org/10.1371/journal.pone.0056964
Buffie CG, Bucci V, Stein RR et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205–208. https://doi.org/10.1038/nature13828
Buttó LF, Haller D (2016) Dysbiosis in intestinal inflammation: cause or consequence. Int J Med Microbiol 306:302–309. https://doi.org/10.1016/j.ijmm.2016.02.010
Chen Z-F, Ai L-Y, Wang J-L et al (2015) Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol 10:1433–1445. https://doi.org/10.2217/fmb.15.66
Comalada M, Bailón E, de Haro O et al (2006) The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol 132:487–497. https://doi.org/10.1007/s00432-006-0092-x
Cryan JF, O’Riordan KJ, Sandhu K et al (2020) The gut microbiome in neurological disorders. Lancet Neurol 19:179–194. https://doi.org/10.1016/S1474-4422(19)30356-4
Cui M, Xiao H, Li Y et al (2017) Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med 9:448–461. https://doi.org/10.15252/emmm.201606932
Czesnikiewicz-Guzik M, Müller DN (2018) Scientists on the spot: salt, the microbiome, and cardiovascular diseases. Cardiovasc Res 114:e72–e73. https://doi.org/10.1093/cvr/cvy171
De Marco S, Sichetti M, Muradyan D et al (2018) Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS. Evid Based Complement Alternat Med 2018:1756308. https://doi.org/10.1155/2018/1756308
De Spiegeleer B, Verbeke F, D’Hondt M et al (2015) The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro. PLoS One 10:e0119471. https://doi.org/10.1371/journal.pone.0119471
De Spiegeleer A, Wynendaele E, Descamps A et al (2022) The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia. Clin Transl Med 12:e1053. https://doi.org/10.1002/ctm2.1053
den Besten G, van Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325–2340. https://doi.org/10.1194/jlr.R036012
Deschasaux M, Bouter KE, Prodan A et al (2018) Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med 24:1526–1531. https://doi.org/10.1038/s41591-018-0160-1
Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811–818. https://doi.org/10.1038/nature06245
Ea F, K H, Jf M et al (2015) Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences of the United States of America 112. https://doi.org/10.1073/pnas.1423854112
Ed K, X S, Y G, et al (2016) Structural change in microbiota by a probiotic cocktail enhances the gut barrier and reduces cancer via TLR2 signaling in a rat model of colon cancer. Digestive diseases and sciences 61:. https://doi.org/10.1007/s10620-016-4238-7
ElRakaiby M, Dutilh BE, Rizkallah MR et al (2014) Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18:402–414. https://doi.org/10.1089/omi.2014.0018
Enright MC, Day NP, Davies CE et al (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008–1015. https://doi.org/10.1128/JCM.38.3.1008-1015.2000
Ewaschuk JB, Walker JW, Diaz H, Madsen KL (2006) Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 136:1483–1487. https://doi.org/10.1093/jn/136.6.1483
Falony G, Joossens M, Vieira-Silva S et al (2016) Population-level analysis of gut microbiome variation. Science 352:560–564. https://doi.org/10.1126/science.aad3503
Gaida MM, Mayer C, Dapunt U et al (2016) Expression of the bitter receptor T2R38 in pancreatic cancer: localization in lipid droplets and activation by a bacteria-derived quorum-sensing molecule. Oncotarget 7:12623–12632. https://doi.org/10.18632/oncotarget.7206
Gamallat Y, Meyiah A, Kuugbee ED et al (2016) Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother 83:536–541. https://doi.org/10.1016/j.biopha.2016.07.001
Gao J, Li Y, Wan Y et al (2019) A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Front Microbiol 10:477. https://doi.org/10.3389/fmicb.2019.00477
Geller LT, Barzily-Rokni M, Danino T et al (2017) Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357:1156–1160. https://doi.org/10.1126/science.aah5043
Gibson G, Scott K, Rastall R et al (2010) Dietary prebiotics: current status and new definition. Food Science and Technology Bulletin: Functional Foods 7:1–19. https://doi.org/10.1616/1476-2137.15880
Goodrich JK, Waters JL, Poole AC et al (2014) Human genetics shape the gut microbiome. Cell 159:789–799. https://doi.org/10.1016/j.cell.2014.09.053
Gopalakrishnan V, Spencer CN, Nezi L et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359:97–103. https://doi.org/10.1126/science.aan4236
Greer JB, O’Keefe SJ (2011) Microbial induction of immunity, inflammation, and cancer. Front Physiol 1:168. https://doi.org/10.3389/fphys.2010.00168
Grivennikov SI, Wang K, Mucida D et al (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491:254–258. https://doi.org/10.1038/nature11465
Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 39:237–238. https://doi.org/10.1016/s0168-1605(97)00136-0
Gupta VK, Paul S, Dutta C (2017) Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Microbiol 8:1162. https://doi.org/10.3389/fmicb.2017.01162
Hinnebusch BF, Meng S, Wu JT et al (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012–1017. https://doi.org/10.1093/jn/132.5.1012
Hohmann EL, Ananthakrishnan AN, Deshpande V (2014) Case records of the massachusetts general hospital. Case 25–2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med 371:668–675. https://doi.org/10.1056/NEJMcpc1400842
Holmes E, Li JV, Marchesi JR, Nicholson JK (2012) Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 16:559–564. https://doi.org/10.1016/j.cmet.2012.10.007
Ito H, Takemura N, Sonoyama K et al (2011) Degree of polymerization of inulin-type fructans differentially affects number of lactic acid bacteria, intestinal immune functions, and immunoglobulin A secretion in the rat cecum. J Agric Food Chem 59:5771–5778. https://doi.org/10.1021/jf200859z
Janssens Y, Debunne N, De Spiegeleer A et al (2021) PapRIV, a BV-2 microglial cell activating quorum sensing peptide. Sci Rep 11:10723. https://doi.org/10.1038/s41598-021-90030-y
Jiang R, Wang H, Deng L et al (2013) IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 13:59. https://doi.org/10.1186/1471-2407-13-59
Kaplan CW, Lux R, Haake SK, Shi W (2009) The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol 71:35–47. https://doi.org/10.1111/j.1365-2958.2008.06503.x
Kaplan CW, Ma X, Paranjpe A et al (2010) Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun 78:4773–4778. https://doi.org/10.1128/IAI.00567-10
Kuijsten A, Arts ICW, Hollman PCH et al (2006) Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 15:1132–1136. https://doi.org/10.1158/1055-9965.EPI-05-0991
Kumar M, Kissoon-Singh V, Coria AL et al (2017) Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Am J Physiol Gastrointest Liver Physiol 312:G34–G45. https://doi.org/10.1152/ajpgi.00298.2016
Kumari A, Pasini P, Deo SK et al (2006) Biosensing systems for the detection of bacterial quorum signaling molecules. Anal Chem 78:7603–7609. https://doi.org/10.1021/ac061421n
Lazar V, Ditu L-M, Pircalabioru GG et al (2018) Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol 9:1830. https://doi.org/10.3389/fimmu.2018.01830
Lederberg J (2000) Infectious history. Science 288:287–293. https://doi.org/10.1126/science.288.5464.287
Leopold SR, Goering RV, Witten A et al (2014) Bacterial whole-genome sequencing revisited: portable, scalable, and standardized analysis for typing and detection of virulence and antibiotic resistance genes. J Clin Microbiol 52:2365–2370. https://doi.org/10.1128/JCM.00262-14
Li X, Watanabe K, Kimura I (2017) Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases. Front Immunol 8:1882. https://doi.org/10.3389/fimmu.2017.01882
Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369–2379. https://doi.org/10.1056/NEJMra1600266
Lyon GJ, Novick RP (2004) Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 25:1389–1403. https://doi.org/10.1016/j.peptides.2003.11.026
Macfarlane S, Woodmansey EJ, Macfarlane GT (2005) Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol 71:7483–7492. https://doi.org/10.1128/AEM.71.11.7483-7492.2005
Marchesi JR, Ravel J (2015) The vocabulary of microbiome research: a proposal. Microbiome 3:31. https://doi.org/10.1186/s40168-015-0094-5
Matson V, Fessler J, Bao R et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359:104–108. https://doi.org/10.1126/science.aao3290
Maynard CL, Elson CO, Hatton RD, Weaver CT (2012) Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:231–241. https://doi.org/10.1038/nature11551
McCarthy JJ, McLeod HL, Ginsburg GS (2013) Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 5:189sr4. https://doi.org/10.1126/scitranslmed.3005785
Monteagudo-Mera A, Rastall RA, Gibson GR et al (2019) Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl Microbiol Biotechnol 103:6463–6472. https://doi.org/10.1007/s00253-019-09978-7
Ng LK, Martin I, Alfa M, Mulvey M (2001) Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes 15:209–215. https://doi.org/10.1006/mcpr.2001.0363
O’Keefe SJD (2016) Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 13:691–706. https://doi.org/10.1038/nrgastro.2016.165
Picard C, Fioramonti J, Francois A et al (2005) Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits. Aliment Pharmacol Ther 22:495–512. https://doi.org/10.1111/j.1365-2036.2005.02615.x
Quera R, Espinoza R, Estay C, Rivera D (2014) Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn’s disease and recurrent Clostridium difficile infection. J Crohns Colitis 8:252–253. https://doi.org/10.1016/j.crohns.2013.10.002
Rafter J, Bennett M, Caderni G et al (2007) Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85:488–496. https://doi.org/10.1093/ajcn/85.2.488
Research C for BE (2020) Update to March 12, 2020 safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. FDA
Rosshart SP, Vassallo BG, Angeletti D et al (2017) Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell 171:1015-1028.e13. https://doi.org/10.1016/j.cell.2017.09.016
Routy B, Le Chatelier E, Derosa L et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91–97. https://doi.org/10.1126/science.aan3706
Rowland I, Gibson G, Heinken A et al (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1–24. https://doi.org/10.1007/s00394-017-1445-8
Roy Sarkar S, Banerjee S (2019) Gut microbiota in neurodegenerative disorders. J Neuroimmunol 328:98–104. https://doi.org/10.1016/j.jneuroim.2019.01.004
Rubinstein MR, Wang X, Liu W et al (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206. https://doi.org/10.1016/j.chom.2013.07.012
Rutherford ST, Bassler BL (2012) Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2:a012427. https://doi.org/10.1101/cshperspect.a012427
Scheline RR (1973) Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev 25:451–523
Schwartz M, Gluck M, Koon S (2013) Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol 108:1367. https://doi.org/10.1038/ajg.2013.164
Shastry RP, Rekha PD (2021) Bacterial cross talk with gut microbiome and its implications: a short review. Folia Microbiol (praha) 66:15–24. https://doi.org/10.1007/s12223-020-00821-5
Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928. https://doi.org/10.1128/IAI.01030-06
Shreiner AB, Kao JY, Young VB (2015) The gut microbiome in health and in disease. Curr Opin Gastroenterol 31:69–75. https://doi.org/10.1097/MOG.0000000000000139
Sivan A, Corrales L, Hubert N et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350:1084–1089. https://doi.org/10.1126/science.aac4255
Smits LP, Bouter KEC, de Vos WM et al (2013) Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145:946–953. https://doi.org/10.1053/j.gastro.2013.08.058
Srinath BS, Shastry RP, Kumar SB (2020) Role of gut-lung microbiome crosstalk in COVID-19. Res Biomed Eng 1–11. https://doi.org/10.1007/s42600-020-00113-4
Staley C, Weingarden AR, Khoruts A, Sadowsky MJ (2017) Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol 101:47–64. https://doi.org/10.1007/s00253-016-8006-6
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Swanson KS, Gibson GR, Hutkins R et al (2020) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17:687–701. https://doi.org/10.1038/s41575-020-0344-2
Tamboli CP, Neut C, Desreumaux P, Colombel JF (2004) Dysbiosis in Inflammatory Bowel Disease Gut 53:1–4. https://doi.org/10.1136/gut.53.1.1
Tsoi H, Chu ESH, Zhang X et al (2017) Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152:1419-1433.e5. https://doi.org/10.1053/j.gastro.2017.01.009
Uhlig F, Grundy L, Garcia-Caraballo S et al (2020) Identification of a quorum sensing-dependent communication pathway mediating bacteria-gut-brain cross talk. iScience 23:101695. https://doi.org/10.1016/j.isci.2020.101695
Veenemans J, Overdevest IT, Snelders E et al (2014) Next-generation sequencing for typing and detection of resistance genes: performance of a new commercial method during an outbreak of extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 52:2454–2460. https://doi.org/10.1128/JCM.00313-14
Vipperla K, O’Keefe SJ (2016) Diet, microbiota, and dysbiosis: a “recipe” for colorectal cancer. Food Funct 7:1731–1740. https://doi.org/10.1039/c5fo01276g
Wang L, Cao H, Liu L et al (2014) Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J Biol Chem 289:20234–20244. https://doi.org/10.1074/jbc.M114.553800
Wang Y, Liu L, Moore DJ et al (2017) An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol 10:373–384. https://doi.org/10.1038/mi.2016.57
Waters CM, Bassler BL (2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 21:319–346. https://doi.org/10.1146/annurev.cellbio.21.012704.131001
Wynendaele E, Debunne N, Janssens Y et al (2022) The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice: a new factor in the host-microbiome interaction. BMC Biol 20:151. https://doi.org/10.1186/s12915-022-01317-z
Wynendaele E, Verbeke F, D’Hondt M et al (2015a) Crosstalk between the microbiome and cancer cells by quorum sensing peptides. Peptides 64:40–48. https://doi.org/10.1016/j.peptides.2014.12.009
Wynendaele E, Verbeke F, Stalmans S et al (2015b) Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier. PLoS One 10:e0142071. https://doi.org/10.1371/journal.pone.0142071
Yada S, Kamalesh B, Sonwane S et al (2015) Quorum sensing inhibition, relevance to periodontics. J Int Oral Health 7:67–69
Yatsunenko T, Rey FE, Manary MJ et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227. https://doi.org/10.1038/nature11053
Yu J, Chen Y, Fu X et al (2016) Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer 139:1318–1326. https://doi.org/10.1002/ijc.30168
Zhernakova A, Kurilshikov A, Bonder MJ et al (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:565–569. https://doi.org/10.1126/science.aad3369
Zhu W, Winter MG, Byndloss MX et al (2018) Precision editing of the gut microbiota ameliorates colitis. Nature 553:208–211. https://doi.org/10.1038/nature25172
Acknowledgements
We thank ICMR-DHR, Government of India, New Delhi, for the funding support (ICMR/5/13/84/2020/NCD-III dated 16/03/2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pal, P., Shastry, R.P. Exploring the complex role of gut microbiome in the development of precision medicine strategies for targeting microbial imbalance-induced colon cancer. Folia Microbiol 68, 691–701 (2023). https://doi.org/10.1007/s12223-023-01085-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-023-01085-5